Skip to main contentSkip to navigation
Sirius Investors
BlossomHill Therapeutics, Inc.

BlossomHill Therapeutics, Inc.

BLSM
NASDAQHealthcare

Market Capitalization & Enterprise Value

Research-grade valuation history for BLSM. Track market capitalization versus enterprise value to see the impact of net debt and share changes. Use the interactive chart to explore different horizons; the table updates accordingly to support auditability and export.

Market Cap & Enterprise Value

Comparison of market capitalization and enterprise value over time

Market Cap

Market Capitalization = Stock Price × Number of Shares Outstanding. Represents the total value of a company's equity.
465.30M
0.00% over period

Enterprise Value

Enterprise Value = Market Cap + Total Debt - Cash and Cash Equivalents. Represents the total value of a company including its debt.
351.01M
-4.01% over period
CAGR: -4.01%
Compound Annual Growth Rate - The mean annual growth rate over time, accounting for compounding effects.

Market Cap History

Investor Valuation Insights

As of Mar 31, 2026

EV/EBITDA

Distorted

-16.94x

Negative EV/EBITDA usually means negative EBITDA; compare with revenue and cash flow metrics.

EV vs Market Cap Spread

-114.28M

EV is -24.6% vs equity value

Capital Structure Signal

Net Cash Profile

EV premium trend: -3.2 pp vs earliest data

Additional Multiples

EV/Sales: 0.00x

Net Debt/EBITDA: 4.23x

Share count change in dataset: +0.00%

Interpretation guide: EV/EBITDA compares total firm value (debt + equity - cash) to operating earnings. Lower is usually cheaper, but always benchmark against peers, growth rate, margins, and cyclicality.

Market Cap & Enterprise Value Data

Free users can view the latest 3 records. Upgrade to see full history.

Upgrade
DateMarket CapEnterprise ValueStock PriceShares
Dec 31, 2025465.30M351.01M$16.0029.08M
Dec 31, 2024465.30M365.68M$16.0029.08M

Enterprise Value Analysis

Price Change (Dec 2024 to Dec 2025)

The stock price has decreased from Dec 2024 to Dec 2025.
0.00%

Recent Volatility

The stock price has been relatively stable over the last 2 periods, indicating a lower risk profile.
0.00

Risk-Adjusted Return

The stock's returns compensate somewhat for its risk, suggesting a moderate investment opportunity.
0.00

Market Cap Change (Dec 2024 to Dec 2025)

The company's market capitalization has decreased from Dec 2024 to Dec 2025.
0.00%

Enterprise Value Change (Dec 2024 to Dec 2025)

The company's enterprise value has decreased from Dec 2024 to Dec 2025, suggesting a decline in the company's total economic value.
-4.01%

Market Cap vs. Enterprise Value

A lower enterprise value growth rate compared to market cap growth could suggest that the company is reducing debt or increasing cash reserves.
Market Cap Growth > EV Growth